Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
China
Biotech
Connect reduces China workforce, mulls strategy for asthma drug
In a year that has seen Connect walk away from a Pfizer collab and halt preclinical work, the biotech is now “significantly reducing” its China presence
James Waldron
Sep 6, 2024 4:37am
Allist pays Jacobio $21M, landing role in Chinese KRAS race
Aug 30, 2024 9:12am
YolTech sells China rights to gene editing therapy for $29M
Aug 27, 2024 10:24am
Merck pays $700M for bispecific challenger to Amgen cancer drug
Aug 9, 2024 8:52am
China’s share of world trials jumps, along with enrollment times
Jul 10, 2024 4:30pm
Day One doles out $55M for MabCare’s solid tumor ADC
Jun 18, 2024 10:55am